Cargando…

Fenofibrate: A Nonlithogenic Means of Recurrent Drug-Induced Pancreatitis

Medications account for a small portion of the various etiologies of acute pancreatitis. Prompt identification of drugs as the inciting factor decreases disease recurrence and unnecessary invasive diagnostic intervention. This case is a report of fenofibrate-induced acute pancreatitis including a di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassim, Thamer, Hermes, Joy-Marie, Abdussalam, Abdullah, Aly, Ahmed, Chandra, Subhash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151234/
https://www.ncbi.nlm.nih.gov/pubmed/30271638
http://dx.doi.org/10.1155/2018/4580860
Descripción
Sumario:Medications account for a small portion of the various etiologies of acute pancreatitis. Prompt identification of drugs as the inciting factor decreases disease recurrence and unnecessary invasive diagnostic intervention. This case is a report of fenofibrate-induced acute pancreatitis including a disease recurrence with continuation of fenofibrate which subsequently resolved after drug discontinuation. The patient underwent invasive diagnostic evaluation including endoscopic ultrasound with fine needle aspiration and endoscopic retrograde cholangiopancreatography (ERCP). Based on exclusion of other disease etiologies and a positive drug rechallenge, fenofibrate fits as a class 1A medication in the classification of drug-induced pancreatitis.